Correction on section g2: company representative was inadvertently checked.Manufacturer's investigation conclusion: a direct correlation between the heartmate (hm) 3 left ventricular assist system (lvas) (b)(6) and the reported events could not be conclusively established through this investigation.The patient remains ongoing on heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(6).No product is available for investigation.The heartmate 3 lvas ifu, rev.C and the heartmate ii patient handbook rev.D are currently available.The heartmate 3 left ventricular assist system instructions for use lists bleeding, cardiac arrhythmia, and wound dehiscence as adverse events, as well as a potential late postimplant complication that may be associated with the use of the heartmate 3 left ventricular assist system.Section 6, ¿patient care and management¿ also provides information regarding anticoagulation, including the recommended international normalized ratio (inr) values.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped on 13feb2022.No further information was provided.The manufacturer is closing the file on this event.
|